In case you missed our webinar on Friday, June 19, 2020 on "Legal Issues and Guidelines Associated with Reopening Practices Post COVID-19" or want to watch it again to get any practice reopening tips you may have missed, we are pleased to share an on demand version of our webinar below. Frier Levitt New York City Office Managing Partner John E. Morrone, Esq., Partner Jesse C. Dresser, Esq., Senior Counsel...

"Medical practices that once eagerly welcomed private equity are finding, thanks to COVID, that grass isn’t always greener..." Read what Frier Levitt Co-founder Daniel Frier, Esq. has to say about private equity financing for medical practices in the current environment in this recent ROI-NJ article.   Click here to view the article. 

Frier Levitt Senior Counsel Lawrence Kobak, DPM, JD shares "Some Medico-Legal Aspects of COVID-19" in the June/July issue of Podiatry Management. You can read this Legal Corner column by clicking here.

With the imminent need for information on government action in regards to medical issues and potential lifesaving treatments during the Covid-19 pandemic, various state and federal agencies have seemingly dismissed the public’s right to transparency. Frier Levitt attorney Nicole DeWitt, Esq. recently authored an article for the Goldwater Institute's "In Defense of Liberty" publication which talks about how the Institute and the Firm are joining together to fight for "terminally...

On May 19, 2020, the Department of Health and Human Services (HHS) issued guidance clarifying whether the Public Readiness and Emergency Preparedness (PREP) Act preempts State licensing laws that restrict pharmacists and pharmacies from ordering and administering FDA-approved COVID-19 tests.  As we discussed in an earlier article, the Office of the Assistant Secretary of Health and Human Services (“OASH”) issued guidance on April 8, 2020 that authorized licensed pharmacists to...